HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

DNA methylation of genes linked with retinoid signaling in gastric carcinoma: expression of the retinoid acid receptor beta, cellular retinol-binding protein 1, and tazarotene-induced gene 1 genes is associated with DNA methylation.

AbstractBACKGROUND:
Hypermethylation of CpG islands has been associated with silencing of various tumor suppressor genes, and the retinoid acid receptor beta (RARbeta), cellular retinol-binding protein 1 (CRBP1), and tazarotene-induced gene 1 (TIG1) genes have been associated with retinoic acid signaling. To the authors' knowledge, little is known regarding the involvement of these three genes in gastric carcinoma (GC). In this study, the authors investigated the methylation status of these genes and analyzed the role of their DNA methylation in GC.
METHODS:
DNA methylation of 3 retinoic acid-associated genes was analyzed in 42 samples of GC from 42 patients and in 8 GC cell lines by methylation-specific polymerase chain reaction (PCR) analysis. The mRNA expression levels for these three genes were measured by quantitative reverse transcription-PCR.
RESULTS:
In 7 of 8 GC cell lines, the CRBP1 gene was hypermethylated, and CRBP1 transcription was inactive. In 6 of 8 GC cell lines, the TIG1 gene was hypermethylated, and TIG1 transcription was inactive. Treatment with demethylating agent 5-aza-2'-deoxycytidine restored both CRBP1 and TIG1 transcription. DNA methylation of the RARbeta, CRBP1, and TIG1 genes was detected in 15 of 42 GC samples (36%), 14 of 42 GC samples (33%), and 4 of 42 GC samples (10%), respectively, and in 6 of 30 samples (20%), 0 of 30 samples (0%), and 1 of 30 samples (3%) of corresponding nonneoplastic mucosa. None of the 10 normal gastric mucosa samples from young, healthy individuals demonstrated hypermethylation of any of these genes. DNA methylation of each gene was associated significantly with low mRNA expression of the respective gene. Twenty-four of 42 GC samples (57%) demonstrated hypermethylation of at least 1 of the 3 genes. However, no significant, concordant hypermethylation of these genes was observed.
CONCLUSIONS:
The results suggested that gastric carcinogenesis involves transcriptional inactivation by aberrant DNA methylation of genes related to retinoid signaling.
AuthorsMariko Shutoh, Naohide Oue, Phyu Phyu Aung, Tsuyoshi Noguchi, Kazuya Kuraoka, Hirofumi Nakayama, Katsunobu Kawahara, Wataru Yasui
JournalCancer (Cancer) Vol. 104 Issue 8 Pg. 1609-19 (Oct 15 2005) ISSN: 0008-543X [Print] United States
PMID16134180 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2005 American Cancer Society
Chemical References
  • Membrane Proteins
  • RARRES1 protein, human
  • RBP1 protein, human
  • RNA, Messenger
  • Receptors, Retinoic Acid
  • Retinoids
  • Retinol-Binding Proteins
  • Retinol-Binding Proteins, Cellular
  • retinoic acid receptor beta
  • Azacitidine
Topics
  • Adenocarcinoma (genetics, pathology)
  • Adult
  • Aged
  • Aged, 80 and over
  • Azacitidine (pharmacology)
  • Carcinoma, Adenosquamous (genetics, pathology)
  • DNA Methylation
  • Female
  • Gastric Mucosa (metabolism, pathology)
  • Gene Expression Regulation, Neoplastic
  • Gene Silencing
  • Genes, Tumor Suppressor
  • Humans
  • Intestinal Neoplasms (genetics, pathology)
  • Male
  • Membrane Proteins (genetics, metabolism)
  • Metaplasia (genetics, pathology)
  • Middle Aged
  • Promoter Regions, Genetic (genetics)
  • RNA, Messenger (genetics, metabolism)
  • Receptors, Retinoic Acid (genetics, metabolism)
  • Retinoids (pharmacology)
  • Retinol-Binding Proteins (genetics, metabolism)
  • Retinol-Binding Proteins, Cellular
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction
  • Stomach Neoplasms (genetics, pathology)
  • Transcription, Genetic
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: